Viewing Study NCT02497118


Ignite Creation Date: 2025-12-25 @ 4:58 AM
Ignite Modification Date: 2026-02-28 @ 5:31 AM
Study NCT ID: NCT02497118
Status: COMPLETED
Last Update Posted: 2015-07-14
First Post: 2015-07-05
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Recombinant Human Endostatin Combined With NP in Neoadjuvant Chemotherapy of Stage ⅢA NSCLC
Sponsor: Tianjin Medical University Cancer Institute and Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module